TRINARA, film-coated tablet 63 tablets
Active ingredients: Norgestimate, Ethinylestradiol
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet63 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- TRINARA, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé et comprimé pelliculé et comprimé pelliculé
- Route of administration
- orale
- Presentation description
- 3 plaquette(s) PVC polyéthylène PVDC aluminium de 21 comprimés (7 comprimés blancs, 7 comprimés bleu clair et 7 comprimés bleus)
- Marketing authorisation holder
- EXELTIS SANTE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 12 Jan 2023
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69274060CIP73025729CIP133400930257296Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ÉTHINYLESTRADIOLcomprimé blanc | 0,035 mg · un comprimé | SA |
| NORGESTIMATEcomprimé blanc | 0,180 mg · un comprimé | SA |
| ÉTHINYLESTRADIOLcomprimé bleu | 0,035 mg · un comprimé | SA |
| NORGESTIMATEcomprimé bleu | 0,250 mg · un comprimé | SA |
| ÉTHINYLESTRADIOLcomprimé bleu clair | 0,035 mg · un comprimé | SA |
| NORGESTIMATEcomprimé bleu clair | 0,215 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.